Xiaobo Lu

机构：Xinjiang Medical University, First Affiliated Hospital of Xinjiang Medical University, Quzhou City People's Hospital, European Foundation for the Study of Chronic Liver Failure · ORCID：0000-0001-5532-7551

发表论文 92 篇 · 总被引 1141 次 · h-index 18

代表论文

• Association of AST/ALT ratio with 90-day outcomes in patients with acute exacerbation of chronic liver disease: a prospective multicenter cohort study in China (2024 · Frontiers in Medicine · 被引 22)
• Rice-derived recombinant human serum albumin as an alternative to human plasma for patients with decompensated liver cirrhosis: a randomised, double-blind, positive-controlled and non-inferiority trial (2025 · Gut · 被引 12)
• Severe anemia is associated with increased short-term and long-term mortality in patients hospitalized with cirrhosis (2023 · Annals of Hepatology · 被引 11)
• The clinical courses of HBV-related acute-on-chronic liver failure and a multi-state model to predict disease evolution (2024 · Hepatology Communications · 被引 10)
• Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19 (2024 · NEJM Evidence · 被引 7)
• sTREM-1 as promising prognostic biomarker for acute-on-chronic liver failure and mortality in patients with acute decompensation of cirrhosis (2024 · World Journal of Gastroenterology · 被引 5)